| (210) | Number of the EPO application | 21758144 |
| (220) | Filing date of the EPO application | 2021.08.06 |
| (80) | EPO patent specification publication (B) | EPB nr. 41/2022, 2022.10.12 |
| (110) | EPO patent number | 3953330 |
| (11) | Number of the document | MD 3953330 T2 |
| (21) | Number of the application | e 2022 0845 |
| (71) | Name(s) of applicant(s), code of the country | Pfizer Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | OWEN Dafydd Rhys, US;
PETTERSSON Martin Youngjin, US;
REESE Matthew Richard, US;
SAMMONS Matthew Forrest, US;
TUTTLE Jamison Bryce, US;
VERHOEST Patrick Robert, US;
WEI Liuqing, US;
YANG Qingyi, US;
YANG Xiaojing, US; |
| (73) | Name(s) of owner(s), code of the country | PFIZER INC., US; |
| (54) | Title of the invention | Nitrile-containing compounds useful as antiviral agents for the treatment of a coronavirus infection |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 207/267 (2006.01.01); C07D 403/12 (2006.01.01); C07D 403/14 (2006.01.01); A61P 31/14 (2006.01.01); C07D 401/12 (2006.01.01); C07D 497/04 (2006.01.01); A61K 31/4015 (2006.01.01); A61K 31/4025 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2022.08.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.01.31 |
| (30) | Priority | 202063073982 P, 2020.09.03, US; 202163143435 P, 2021.01.29, US; 202163170158 P, 2021.04.02, US; 202163194241 P, 2021.05.28, US |
| (74) | Patent attorney | (Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova |
| (86) | International application | PCT/IB2021/057281, 2021.08.06 |
| (87) | International publication | WO 2021/250648, 2021.12.16 |